$RMT

CLARK CHRISTOPHER D purchased $13K of RMT

CLARK CHRISTOPHER D (President) purchased 1,000 shares of ROYCE MICRO-CAP TRUST, INC. (RMT) at $13.40 on 2026-09-30.

Original reporting
SEC EDGAR · CLARK CHRISTOPHER D
Published Oct 1, 2026, 8:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RMT
Neutral
medium confidence
Mentioned
$RMT
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RMTNeutralLow
01

Why it matters

The purchase is modest and unlikely to affect price, but may be noted by algorithmic traders tracking insider activity.

02

Market read

A routine insider purchase with limited material impact; primarily of interest to niche micro‑cap traders.

03

What to watch

Potential upcoming corporate actions or fund flows not disclosed in the filing.

Relevance 4/10Novelty 4/10Timing: after-hours filing

Background

Form 4 filings disclose insider transactions; investors monitor them for signals of confidence or distress.

Company-level read

Ticker impact

$RMTNeutralMedium confidence
Context

President Clark Christopher D bought 1,000 shares of Royce Micro-Cap Trust for $13,400, increasing his stake to 76,624 shares.

Expected impact

slight upward pressure as market absorbs insider buying

Evidence & confidence

The transaction size ($13.4k) is modest for a micro‑cap, unlikely to move price materially but could be noted by traders.

Market effects

Minimal; micro‑cap trust sector sees typical insider activity.

None; company is US‑based with limited regional relevance.

None

Counterpoint

Insider buying could be a contrarian signal if the stock is undervalued.

Key entities

  • Royce Micro-Cap Trust, Inc.

    Micro‑cap investment trust listed in the US.

  • Clark Christopher D.

    President and director of Royce Micro‑Cap Trust.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).